Baxter International Inc (NYSE: BAX)

Baxter International Inc provides a broad portfolio of essential healthcare products, including sterile intravenous solutions, infusion systems, parenteral nutrition therapies, inhaled anesthetics, generic injectable pharmaceuticals, surgical hemostat and sealant products, advanced surgical equipment, smart bed systems, patient monitoring and diagnostic technologies, and respiratory health devices. The company operates in the healthcare industry, catering to a diverse range of customers such as hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. Baxter International Inc generates revenue through the sale of these products, which are used in various healthcare settings. The company's primary products include sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies, surgical hemostat, sealant and adhesion prevention products, connected care solutions, smart bed systems, patient monitoring systems, diagnostic technologies, respiratory health devices, advanced surgical equipment, specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. These products cater to a broad customer base, including healthcare facilities and patients requiring home-based therapies.

• Medical Products & Therapies: This segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies, and surgical hemostat, sealant, and adhesion prevention products. These products are designed to address various medical needs and are used in hospitals, clinics, and home care settings.

• Healthcare Systems & Technologies: This segment focuses on connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems, diagnostic technologies, respiratory health devices, and advanced surgical equipment. These technologies aim to enhance patient care and operational efficiency in healthcare facilities.

• Pharmaceuticals: This segment encompasses sales of specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. These products are used in various medical procedures and treatments, catering to both inpatient and outpatient settings.

Baxter International Inc holds a significant position in the healthcare industry, competing with various international and domestic healthcare, medical products, and pharmaceutical companies. The company's competitive advantages include the breadth and depth of its product offerings, strong relationships with customers, efficiencies from shared manufacturing facilities, and technological advantages of its products. Baxter International Inc's products are sold through contracts with customers, both within and outside the United States. These contracts may have terms of more than one year and place limits on price increases. The company's customer base includes hospitals, governments, other facilities, and group purchasing organizations (GPOs) or integrated delivery networks (IDNs) that negotiate pricing arrangements. Baxter International Inc's products are distributed through its own direct sales force and independent distributors or sales agents in more than 100 countries. The company's global presence and the critical nature of its products play a key role in expanding access to healthcare in both emerging and developed countries.